MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
REGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Regeneron Pharmaceuticals (REGN) Ownership - Who owns Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
777 Old Saw Mill River Road
Phone
+1 914 847-7000
Employees
15410
Web
https://www.regeneron.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
82.06B
P/E Ratio
19.72
Total Cash
7.99B
Projected Growth
1.35
Total Debt
2.71B
Revenue
15.53B
Risk (Beta)
-0.09
Dividend Yield
0.00
Total Cash/Share
77.65
Total Debt/Equity
24.02
Revenue/Share
145.12 USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
REGN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for REGN
A.I. Advisor
published General Information

General Information

a developer of medicines for the treatment of serious medical conditions

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
777 Old Saw Mill River Road
Phone
+1 914 847-7000
Employees
15410
Web
https://www.regeneron.com